A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma

BACKGROUND: This study aimed to develop a reliable immune signature based on B-cell proportion to predict the prognosis and benefit of immunotherapy in LUAD. METHODS: The proportion of immune cells in the TCGA-LUAD dataset was estimated using MCP-counter. The Least Absolute Shrinkage and Selector Op...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Yin, Xuewen, Wang, Qi, Song, Xuming, Xia, Wenjie, Mao, Qixing, Chen, Bing, Liang, Yingkuan, Zhang, Te, Xu, Lin, Jiang, Feng, Xu, Xinyu, Dong, Gaochao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513350/
https://www.ncbi.nlm.nih.gov/pubmed/34641822
http://dx.doi.org/10.1186/s12885-021-08805-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513350/
https://www.ncbi.nlm.nih.gov/pubmed/34641822
http://dx.doi.org/10.1186/s12885-021-08805-5

Ejemplares similares